BioCentury
ARTICLE | Clinical News

Melanotan: Completed Phase II enrollment

October 10, 2005 7:00 AM UTC

EPT completed enrollment of 45 subjects in the double-blind, placebo-controlled, Australian Phase II EP008 trial. ...